Phylos Bioscience, Inc., 2025-12-19
An SEC Form D private-offering notice from Portland, OR, an undisclosed offering target in Biotech. Filed 2025-12-19. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Phylos Bioscience is a Portland based agricultural biotechnology company that uses DNA sequencing and genomics to improve cannabis and hemp varieties.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Northwest Natural Spirits, LLC, 2025-12-31, $7M, Beaverton, OR
- Aeovian Pharmaceuticals, Inc., 2025-12-22, $55M, Berkeley, CA
- Kivo, Inc., 2025-12-31, $5.1M, Portland, OR
- Amphix Bio, Inc., 2025-12-19, $12.5M, Chicago, IL
- StrateSea Technology, Inc., 2025-12-23, Lake Oswego, OR
- Avana Health, Inc., 2025-12-19, $4M, Lexington, KY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.